Literature DB >> 19379291

Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients.

Agatino Battaglia1, Tiziana Filippi, Sarah T South, John C Carey.   

Abstract

To define the spectrum of epilepsy in Wolf-Hirschhorn syndrome (WHS) better, we studied 87 patients (54 females, 33 males; median age 5.6 years; age range 1-25.6 years) with confirmed 4p16.3 deletion. On the basis of clinical charts, we retrospectively analyzed the evolution of the electroencephalogram (EEG) findings and seizures. Epilepsy occurred in 81 patients (93%) within the first 3 years of life. Sixty out of 81 (74%) had generalized tonic-clonic seizures, which was the only seizure pattern in 32. Tonic spasms occurred in 15 out of 81 (18%), complex partial seizures in 10 out of 81 (12%), and clonic seizures in 6 out of 81 (7%). Seizures were frequently triggered by fever (59 out of 81; 73%), and occurred in clusters in 36 out of 72 (50%). In the same 36 (50%), unilateral or generalized clonic or tonic-clonic status epilepticus occurred during the first 3 years of life. Twenty-seven out of 81 patients (33%) developed atypical absences between 1 and 6 years, accompanied by a myoclonic component involving the eyelids and the hands. Distinctive EEG abnormalities were observed in 73 out of 81 (90%). Epilepsy was well controlled in 65 out of 81 (81%), mainly with valproate and phenobarbital, and improved with age in all. Thirty-two out of 58 (55%) are currently seizure-free. Seizures stopped at a median age of 4 years 6 months. Epilepsy represents a major clinical challenge in WHS; however, it has a good prognosis. Early diagnosis and treatment of atypical absences, subtle and often misdiagnosed, is mandatory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19379291     DOI: 10.1111/j.1469-8749.2008.03233.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

1.  Clinical utility gene card for: Wolf-Hirschhorn (4p-) syndrome.

Authors:  Agatino Battaglia; Sarah South; John C Carey
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome.

Authors:  Zeynep Selen Karalok; Ebru Petek Arhan; Kadri Murat Erdogan; Esra Gurkas
Journal:  Childs Nerv Syst       Date:  2015-11-20       Impact factor: 1.475

4.  Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome.

Authors:  Francis M Filloux; John C Carey; Ian D Krantz; Jeffrey J Ekstrand; Meghan S Candee
Journal:  Eur J Med Genet       Date:  2012-02-01       Impact factor: 2.708

Review 5.  Genetic forms of epilepsies and other paroxysmal disorders.

Authors:  Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

6.  Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome.

Authors:  Thiago Corrêa; Maytza Mayndra; Cíntia B Santos-Rebouças
Journal:  Mol Neurobiol       Date:  2022-03-12       Impact factor: 5.590

7.  Analyses of Genotypes and Phenotypes of Ten Chinese Patients with Wolf-Hirschhorn Syndrome by Multiplex Ligation-dependent Probe Amplification and Array Comparative Genomic Hybridization.

Authors:  Wen-Xu Yang; Hong Pan; Lin Li; Hai-Rong Wu; Song-Tao Wang; Xin-Hua Bao; Yu-Wu Jiang; Yu Qi
Journal:  Chin Med J (Engl)       Date:  2016-03-20       Impact factor: 2.628

8.  A case for cannabidiol in Wolf-Hirschhorn syndrome seizure management.

Authors:  Karen S Ho; E Robert Wassman
Journal:  Am J Med Genet A       Date:  2016-11-07       Impact factor: 2.802

9.  LETM1 haploinsufficiency causes mitochondrial defects in cells from humans with Wolf-Hirschhorn syndrome: implications for dissecting the underlying pathomechanisms in this condition.

Authors:  Lesley Hart; Anita Rauch; Antony M Carr; Joris R Vermeesch; Mark O'Driscoll
Journal:  Dis Model Mech       Date:  2014-03-13       Impact factor: 5.758

10.  Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.

Authors:  Karen S Ho; Sarah T South; Amanda Lortz; Charles H Hensel; Mallory R Sdano; Rena J Vanzo; Megan M Martin; Andreas Peiffer; Christophe G Lambert; Amy Calhoun; John C Carey; Agatino Battaglia
Journal:  J Med Genet       Date:  2016-01-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.